Long-term every-other-day administration of DMAMCL has little effect on aging and age-associated physiological decline in mice.

Although high dose DMAMCL treatment also mitigated the glucose levels at OGTT, the difference did not reach statistical significance ( Fig. 5R , and FFig.

also in 111,027 other papers